CompletedPhase 4NCT01165840
Effect of Weight and/or Obesity on Dapsone Drug Concentrations
Studying Leprosy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Texas Tech University Health Sciences Center
- Principal Investigator
- Ronald Hall, PharmD, MSCSTexas Tech UHSC
- Intervention
- Dapsone(drug)
- Enrollment
- 37 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2010 – 2012
Study locations (1)
- University of Texas Southwestern, Dallas, Texas, United States
Collaborators
National Center for Research Resources (NCRR)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01165840 on ClinicalTrials.govOther trials for Leprosy
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06761469Leprosy Active Searching Trial in BrazilHospital Alemão Oswaldo Cruz
- RECRUITINGNANCT06819449Rab 32 Gene Polymorphisms as a Prognostic Factor in Leprosy PatientsSouth Valley University
- RECRUITINGNCT06683690TGF β 1 Expression Related Gene PolymorphismAswan University
- RECRUITINGPHASE3NCT05597280Bedaquiline Enhanced Post ExpOsure Prophylaxis for LeprosyInstitute of Tropical Medicine, Belgium
- RECRUITINGPHASE2NCT05243654Efficacy and Tolerability of Adjunct Metformin for Multibacillary LeprosyOxford University Clinical Research Unit Indonesia
- RECRUITINGNANCT06222372Novel Interventions and Diagnostic Tests for LeprosyAnnemieke Geluk